FDA Brief: Week of Feb 22, 2016


FDA Voice

Strengthening Regulatory Relationships in India

By:  Mathew T. Thomas, Director,  and Dean Rugnetta, Deputy Director, FDA’s India Office, New Delhi, India

  •  India is one of the largest suppliers of drug products to US
  • FDA India office established in 2008 to promote govt. -to-govt. interactions
  • Working with counterparts in Indian government to ensure manufactured medical products meet FDA’s safety and quality requirements
  • Meeting of India and US offices held in Nov. 2015 to learn respective regulatory perspectives
  • Continue leveraging knowledge and strengths to ensure patient safety in India and product quality of FDA-regulated pharmaceuticals.




Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account.
Log Out / 
Change )

Google photo

You are commenting using your Google account.
Log Out / 
Change )

Twitter picture

You are commenting using your Twitter account.
Log Out / 
Change )

Facebook photo

You are commenting using your Facebook account.
Log Out / 
Change )

Connecting to %s